| Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 Q Zhang, P Bastard, Z Liu, J Le Pen, M Moncada-Velez, J Chen, M Ogishi, ... Science 370 (6515), eabd4570, 2020 | 2116 | 2020 |
| Type 1 interferons as a potential treatment against COVID-19 E Sallard, FX Lescure, Y Yazdanpanah, F Mentre, N Peiffer-Smadja Antiviral research 178, 104791, 2020 | 603 | 2020 |
| Experimental treatment with favipiravir for Ebola virus disease (the JIKI Trial): a historically controlled, single-arm proof-of-concept trial in Guinea D Sissoko, C Laouenan, E Folkesson, AB M’lebing, AH Beavogui, S Baize, ... PLoS medicine 13 (3), e1001967, 2016 | 574 | 2016 |
| Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ... Science immunology 6 (62), eabl4340, 2021 | 426 | 2021 |
| Prognostic value of muscle atrophy in cirrhosis using psoas muscle thickness on computed tomography F Durand, S Buyse, C Francoz, C Laouénan, O Bruno, J Belghiti, ... Journal of hepatology 60 (6), 1151-1157, 2014 | 382 | 2014 |
| Pregnancy outcomes after ZIKV infection in French territories in the Americas B Hoen, B Schaub, AL Funk, V Ardillon, M Boullard, A Cabié, C Callier, ... New England Journal of Medicine 378 (11), 985-994, 2018 | 365 | 2018 |
| X-linked recessive TLR7 deficiency in~ 1% of men under 60 years old with life-threatening COVID-19 T Asano, B Boisson, F Onodi, D Matuozzo, M Moncada-Velez, ... Science immunology 6 (62), eabl4348, 2021 | 321 | 2021 |
| A comparison of four serological assays for detecting anti–SARS-CoV-2 antibodies in human serum samples from different populations L Grzelak, S Temmam, C Planchais, C Demeret, L Tondeur, C Huon, ... Science translational medicine 12 (559), eabc3103, 2020 | 254 | 2020 |
| Predictive factors of early mortality after transcatheter aortic valve implantation: individual risk assessment using a simple score B Iung, C Laouénan, D Himbert, H Eltchaninoff, K Chevreul, ... Heart, heartjnl-2013-305314, 2014 | 224 | 2014 |
| Clopidogrel plus aspirin versus warfarin in patients with stroke and aortic arch plaques P Amarenco, S Davis, EF Jones, AA Cohen, WD Heiss, M Kaste, ... Stroke 45 (5), 1248-1257, 2014 | 209 | 2014 |
| Modeling SARS-CoV-2 viral kinetics and association with mortality in hospitalized patients from the French COVID cohort N Néant, G Lingas, Q Le Hingrat, J Ghosn, I Engelmann, Q Lepiller, ... Proceedings of the National Academy of Sciences 118 (8), e2017962118, 2021 | 197 | 2021 |
| Favipiravir pharmacokinetics in Ebola-infected patients of the JIKI trial reveals concentrations lower than targeted THT Nguyen, J Guedj, X Anglaret, C Laouénan, V Madelain, AM Taburet, ... PLOS Neglected Tropical Diseases 11 (2), e0005389, 2017 | 178 | 2017 |
| Late results of percutaneous mitral commissurotomy up to 20 years: development and validation of a risk score predicting late functional results from a series of 912 patients C Bouleti, B Iung, C Laouénan, D Himbert, E Brochet, D Messika-Zeitoun, ... Circulation 125 (17), 2119-2127, 2012 | 137 | 2012 |
| Persistent COVID-19 symptoms are highly prevalent 6 months after hospitalization: results from a large prospective cohort J Ghosn, L Piroth, O Epaulard, P Le Turnier, F Mentré, D Bachelet, ... Clinical Microbiology and Infection 27 (7), 1041. e1-1041. e4, 2021 | 133 | 2021 |
| The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies J Manry, P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, ... Proceedings of the National Academy of Sciences 119 (21), 2022 | 125 | 2022 |
| Review of trials currently testing treatment and prevention of COVID-19 PC Fragkou, D Belhadi, N Peiffer-Smadja, CD Moschopoulos, FX Lescure, ... Clinical Microbiology and Infection 26 (8), 988-998, 2020 | 114 | 2020 |
| Prediction of disease reactivation in asymptomatic hepatitis B e antigen-negative chronic hepatitis B patients using baseline serum measurements of HBsAg and HBV-DNA M Martinot-Peignoux, M Lapalus, C Laouénan, O Lada, ... Journal of Clinical Virology 58 (2), 401-407, 2013 | 111 | 2013 |
| Risk factors for postoperative pneumonia after cardiac surgery and development of a preoperative risk score* N Allou, R Bronchard, J Guglielminotti, MP Dilly, S Provenchere, JC Lucet, ... Critical care medicine 42 (5), 1150-1156, 2014 | 105 | 2014 |
| Phylogenetic distribution of CTX-M-and non-extended-spectrum-β-lactamase-producing Escherichia coli isolates: group B2 isolates, except clone ST131, rarely produce CTX-M enzymes S Brisse, L Diancourt, C Laouénan, M Vigan, V Caro, G Arlet, L Drieux, ... Journal of clinical microbiology 50 (9), 2974-2981, 2012 | 88 | 2012 |
| COVID-STORM Clinicians; COVID Clinicians; Imagine COVID Group; French COVID Cohort Study Group; CoV-Contact Cohort; Amsterdam UMC Covid-19 Biobank; COVID Human Genetic Effort Q Zhang, P Bastard, Z Liu, J Le Pen, M Moncada-Velez, J Chen, M Ogishi, ... NIAID-USUHS/TAGC COVID Immunity Group, Inborn errors of type I IFN immunity …, 2020 | 84 | 2020 |
Pr France MentrePr of Biostatistics, University Paris DiderotVerified email at inserm.fr
